Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPR1020 in Advanced Solid Tumors (Phase I/II, China)
CTR20254896Phase 2Active
- Sponsor
- Sipure
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SPR1020 in Nonhematologic neoplasms, breast cancer, ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Sipure. Started Jan 2026; status: active.
02
Drugs
SPR1020
03
Conditions
Nonhematologic neoplasmsbreast cancerovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on CTR20254896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254896.